Daniel Brodie is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Brodie is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), COVID-19, Respiratory Acidosis, Lung Transplant, and Embolectomy.

Dr. Allison Hays is a general cardiologist and Medical Director of Echocardiography Programs at the Johns Hopkins Hospital. She is also an assistant professor at the Johns Hopkins University School of Medicine. Dr. Hays graduated from Stanford University with degrees in biology and English. She received her medical training at the Columbia University College of Physicians and Surgeons and did her residency at the New York Presbyterian Hospital at Columbia. Dr. Hays pursued cardiology fellowships at New York University Medical Center and at the Johns Hopkins University School of Medicine. Dr. Hays studies ways to use noninvasive imaging to detect cardiovascular disease. She has advanced multimodality imaging training from Johns Hopkins and attends in the Adult Echocardiography Lab at Johns Hopkins Hospital. In terms of research, she uses Cardiac MRI as a tool to study coronary and systemic endothelial function. Dr. Hays is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Familial Ventricular Tachycardia, Cardiomyopathy, COVID-19, Heart Attack, and Tissue Biopsy.

Dr. Hager is a specialist in Critical Care Medicine. He is an expert in the diagnosis and management of all forms of acute respiratory failure, including asthma, pneumonia, C.O.P.D., neuromuscular diseases, and the acute respiratory distress syndrome. He also has extensive experience in the management of other life-threatening conditions such as pulmonary embolism, gastrointestinal hemorrhage, shock from sepsis, hypovolemia, and heart disease, and metabolic emergencies such as diabetic ketoacidosis and hyperosmolar states. Dr. Hager is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Severe Acute Respiratory Syndrome (SARS), COVID-19, Acute Respiratory Distress Syndrome (ARDS), and Cerebral Hypoxia.

Dr. Werbel is a physician-scientist who provides consultative care for patients at Johns Hopkins who experience infectious disease complications before and after organ transplant, as well as in the setting of solid tumors or blood cancers. His research with the Johns Hopkins Transplant Research Center uses a combination of epidemiological and laboratory methods to better personalize the prevention of infectious complications among patients with complex immunodeficiencies. This includes using national cohort studies and clinical trials to optimize the use of vaccines and other prophylactic therapies for high-risk immunosuppressed populations. Dr. Werbel is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), HIV/AIDS, and Hepatitis.

Dr. Nisha A. Gilotra is a cardiologist in the Johns Hopkins Medicine Division of Cardiology with expertise in advanced heart failure, including the care of heart transplant and ventricular assist device patients. Dr. Gilotra specializes in inflammatory cardiomyopathies, including sarcoidosis, myocarditis and inherited causes of cardiomyopathy. Dr. Gilotra received her medical degree from Jefferson Medical College in Philadelphia, PA. She completed her medical residency, general cardiology fellowship and advanced heart failure fellowship at Johns Hopkins University School of Medicine. Between fellowships, she served as an Assistant Chief of Service for the Department of Medicine. Dr. Gilotra is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Sarcoidosis, Myocarditis, Cardiomyopathy, Heart Transplant, and Endoscopy.

Olivia Kates is an Infectious Disease provider in Baltimore, Maryland. Dr. Kates is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are COVID-19, Diphtheria, Severe Acute Respiratory Syndrome (SARS), and Listeriosis.

Dr. Anum Minhas attended medical school at Duke University and trained in internal medicine at the University of Michigan, Ann Arbor. During her Cardiology fellowship training at Johns Hopkins University School of Medicine, she served as the Chief Cardiology fellow and was honored to receive the Marie-Josee and Henry R. Kravis Endowed Fellowship and the Lou and Nancy Grasmick Endowed Research Fellowship (2021-2022). She was also awarded the Dlabal Clinical Research award for originality and creativity in research. During her fellowship, she completed additional training and obtained a Master of Health Science with focus in cardiovascular epidemiology as an NIH T32 postdoctoral fellow at the Johns Hopkins Bloomberg School of Public Health. She also completed additional clinical training during fellowship in Advanced Echocardiography, and designed and completed an inaugural fellowship in Cardio-Obstetrics. Dr. Minhas joined the Johns Hopkins Cardiology faculty with a clinical focus in women's cardiovascular health, specifically Cardio-Obstetrics, or cardiac disease around pregnancy. She also attends in the coronary critical care unit and the echocardiography laboratory. She was selected as a recipient of an NIH-sponsored KL2 award through the Clinical Research Scholars Program. Her current research focuses on preventing and managing cardiovascular disease associated with pregnancy complications, such as preeclampsia. She is the recipient of several grants and has coauthored multiple publications and book chapters in women's cardiovascular health. She hopes to use her research to raise awareness of and provide insights into mechanisms of pregnancy-associated cardiac disease and promote health equity in maternal health. Videos Community ConversationMaternal Health Recent News Articles and Media Coverage https://the1a.org/segments/in-good-health-unpacking-heart-disease-in-women/ In Good Health: Medical missteps for women with heart disease, NPR Podcast. Dr. Minhas is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Peripartum Cardiomyopathy, Pulmonary Edema, COVID-19, and Cardiomyopathy.

John Baddley is an Infectious Disease provider in Baltimore, Maryland. Dr. Baddley is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Cryptococcosis, Shingles, Sepsis, and Febrile Neutropenia.

Dr. Annie Antar is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include internal medicine and infectious diseases. Her areas of research expertise include long COVID, long COVID in people living with HIV, HIV cure, and suboptimal CD4 response after antiretroviral therapy. Dr. Antar earned her undergraduate degree from Harvard University and her M.D. and Ph.D. degrees from Vanderbilt University School of Medicine. She completed both her residency in internal medicine and fellowship in infectious diseases at the Johns Hopkins Hospital. Dr. Antar is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Long Haul COVID, Severe Acute Respiratory Syndrome (SARS), COVID-19, and HIV/AIDS.

Kathleen Neuzil is an Infectious Disease provider in Baltimore, Maryland. Dr. Neuzil is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Typhoid Fever, Salmonella Enterocolitis, Flu, and COVID-19.

Dr. Kathleen Page is a Professor of Medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include infectious diseases, HIV/AIDS, substance use disorder. She received her undergraduate degree in public health from Johns Hopkins and earned her M.D. from Washington University School of Medicine. She completed her residency at the Hospital of the University of Pennsylvania and performed a fellowship in infectious diseases at Johns Hopkins. Dr. Page joined the Johns Hopkins faculty in 2006. Dr. Page is dedicated to improving access to high-quality care for underserved communities, including people living with HIV, migrants, and individuals with substance use disorders. Her research spans migrant health, infectious diseases, health and human rights, mobile health interventions, and implementation science. As the principal investigator on multiple grants, she leads studies on integrated care models for behavioral health, mHealth tools for HIV care, and strategies to increase equitable access to evidence-based health interventions. Dr. Page is Co-Director of the Center for Community and Global Health in Infectious Diseases (CCGHE-ID) whose mission is to improve health and equity, locally and abroad, through infectious diseases scientific research, training, advocacy, and service. Dr. Page is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are HIV/AIDS, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Hepatitis C.

Matthew Robinson, MD, is Assistant Professor in the Division of Infectious Diseases at Johns Hopkins University School of Medicine. He is interested in leveraging diagnostic innovation and precision medicine to reduce diagnostic and prognostic uncertainty for infectious diseases. His current projects include applications in global health, antimicrobial resistance, antibiotic stewardship, infection control, COVID-19, acute febrile illness, and tuberculosis. After undergraduate and medical school at Northwestern University, he completed internal medicine residency at New York University and Infectious Diseases fellowship at Johns Hopkins School of Medicine. During medical school, he worked at the Chinese Center for Disease Control and Prevention in Beijing, China under a Doris Duke International Clinical Research Fellowship. He also served as a clinician educator in internal medicine in Gulu, Uganda at the Gulu University Faculty of Medicine as a Global Health Service Partnership volunteer. As a fellow, he pursued a Fogarty Global Health Fellowship in Pune, India and an Antibacterial Resistance Leadership Group Fellowship. Since joining the faculty in 2019, Dr. Robinson has been supported by the Centers for Disease Control and Prevention, National Institutes of Health, and Food and Drug Administration. The focus of his work in antimicrobial resistance, antibiotic stewardship, infection control has been to characterize drug-resistant Gram-negative infections in India. His work with the Johns Hopkins Precision Medicine Center of Excellence for COVID-19 has included applying machine learning and causal inference techniques to predict COVID-19 outcomes. He has contributed to SARS-CoV-2 diagnostic development through the NIH Rapid Acceleration of Diagnostics (RADx) initiative and through collaborative development of other novel diagnostics. Dr. Robinson is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Severe Acute Respiratory Syndrome (SARS), COVID-19, Togaviridae Disease, and Dengue Fever.

Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, and Hepatitis B.

Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Theodore Iwashyna is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Iwashyna is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Severe Acute Respiratory Syndrome (SARS), Cerebral Hypoxia, and COVID-19.

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are HIV/AIDS, Cryptococcosis, Gonorrhea, Meningitis, and Tissue Biopsy.

Dr. Bailey received his M.D. and Ph.D. degrees from the Johns Hopkins University School of Medicine through the Medical Scientist Training Program and completed medical residency at the Massachusetts General Hospital. He subsequently completed fellowship training in Infectious Diseases at the Johns Hopkins University School of Medicine before transitioning to a faculty position. His primary clinical interests are management and treatment of HIV and viral hepatitis, including hepatitis c virus. His research interests include the study of human B cells and neutralizing antibody responses against hepatitis C virus (HCV), hepatitis B virus (HBV), SARS-CoV-2, and respiratory syncytial virus (RSV), with the goal of developing improved vaccines against these viruses. Dr. Bailey is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Hepatitis C, Hepatitis, COVID-19, and HIV/AIDS.

Dr. Chad H. Hochberg is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine at Johns Hopkins University. Dr. Hochberg earned his M.D. at the University of Chicago after which he came to Johns Hopkins and completed an internal medicine residency and fellowship in Pulmonary and Critical Care Medicine. During this time Dr. Hochberg served as an Assistant Chief of Service for the Osler Training program, and earned a Masters in Clinical Research from the Johns Hopkins Bloomberg School of Public Health. As a clinician scientist, Dr. Hochberg is engaged in an active practice as an intensivist across intensive care units in the Johns Hopkins Health System. He connects this clinical experience with a research agenda that uses tools from implementation science and health informatics to broaden adoption and foster optimization of evidence-based interventions for patients suffering from critical illness. Dr. Hochberg is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), COVID-19, Ocular Hypertension (OHT), and Severe Acute Respiratory Syndrome (SARS).

Sophia Purekal is a primary care provider, practicing in Addiction Medicine in Baltimore, Maryland. Dr. Purekal is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are COVID-19, Multisystem Inflammatory Syndrome in Children (MIS-C), Opioid Use Disorder, and Glucocorticoid-Remediable Aldosteronism.

Dr. Ishaan Gupta is on the faculty at the Johns Hopkins University School of Medicine. His area of clinical expertise is internal medicine. He received his M.B.B.S. from Pt. B.D. Sharma Post Graduate Institute of Medical Science and completed his residency at Good Samaritan Hospital. Dr. Gupta is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), Orthostatic Hypotension, Empyema, and Endoscopy.